UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection

Journal of dental research, 2018-10, Vol.97 (11), p.1252-1259

2018

Volltextzugriff (PDF)

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study

The Lancet (British edition), 2009-07, Vol.374 (9683), p.48-55

2009

Volltextzugriff (PDF)

Systematic Techniques to Enhance rEtention in Randomised controlled trials: the STEER study protocol

Trials, 2018-03, Vol.19 (1), p.197-197, Article 197

2018

Volltextzugriff (PDF)

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)

Annals of oncology, 2008-09, Vol.19 (9), p.1578-1583

2008

Volltextzugriff (PDF)

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Journal of clinical oncology, 2002-04, Vol.20 (7), p.1838-1844

2002

Volltextzugriff (PDF)

Choriocarcinoma and partial hydatidiform moles

The Lancet (British edition), 2000-07, Vol.356 (9223), p.36-39

2000

Volltextzugriff (PDF)

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy

BJOG : an international journal of obstetrics and gynaecology, 2003-01, Vol.110 (1), p.22-26

2003

Volltextzugriff (PDF)

Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4862-4866

2006

Volltextzugriff (PDF)

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Cancer treatment reviews, 1997, Vol.23 (1), p.35-61

1997

Volltextzugriff (PDF)

Pilot randomised controlled trial of Weight Watchers® referral with or without dietitian-led group support for weight loss in women treated for breast cancer: the BRIGHT (BReast cancer weIGHT loss) trial

Pilot and feasibility studies, 2019-02, Vol.5 (1), p.24-24, Article 24

2019

Volltextzugriff (PDF)

Phase I trial of temozolomide using an extended continuous oral schedule

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (19), p.4363-4367

1998

Volltextzugriff (PDF)

Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors

Journal of clinical oncology, 2000-02, Vol.18 (4), p.854-859

2000

Volltextzugriff (PDF)

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2636-2643

1997

Volltextzugriff (PDF)

Utility of Commonly Used Commercial Human Chorionic Gonadotropin Immunoassays in the Diagnosis and Management of Trophoblastic Diseases

Clinical chemistry (Baltimore, Md.), 2001-02, Vol.47 (2), p.308-315

2001

Volltextzugriff (PDF)

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

Journal of clinical oncology, 1995-04, Vol.13 (4), p.910-913

1995

Volltextzugriff (PDF)

Phase I trial of elactocin

British journal of cancer, 1996-08, Vol.74 (4), p.648-649

1996

Volltextzugriff (PDF)

The views of health care professionals about selective decontamination of the digestive tract: An international, theoretically informed interview study

Journal of critical care, 2014-08, Vol.29 (4), p.634-640

2014

Volltextzugriff (PDF)

Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin

The Lancet (British edition), 2002-06, Vol.359 (9324), p.2165-2166

2002

Volltextzugriff (PDF)

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

Cancer chemotherapy and pharmacology, 1997, Vol.40 (6), p.484-488

1997

Volltextzugriff (PDF)

The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN)

Best practice & research. Clinical obstetrics & gynaecology, 2003-12, Vol.17 (6), p.905-923

Newlands, E.S.

2003

Volltextzugriff (PDF)

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2769-2773

1996

Volltextzugriff (PDF)

Surveillance policy for stage I ovarian germ cell tumors

Journal of clinical oncology, 1997-02, Vol.15 (2), p.620-624

1997

Volltextzugriff (PDF)

Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles

Histopathology, 2001-11, Vol.39 (5), p.447-454

2001

Volltextzugriff (PDF)

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

British journal of cancer, 2003-07, Vol.89 (2), p.248-251

2003

Volltextzugriff (PDF)

Posterior reversible encephalopathy syndrome : a possible late interaction between cytotoxic agents and general anaesthesia

Neuroradiology, 2005-08, Vol.47 (8), p.586-590

2005

Volltextzugriff (PDF)

1 – 25 von 2.333

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.448)
Mit Volltextzugriff
(1.706)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study

Systematic Techniques to Enhance rEtention in Randomised controlled trials: the STEER study protocol

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Choriocarcinoma and partial hydatidiform moles

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy

Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Pilot randomised controlled trial of Weight Watchers® referral with or without dietitian-led group support for weight loss in women treated for breast cancer: the BRIGHT (BReast cancer weIGHT loss) trial

Phase I trial of temozolomide using an extended continuous oral schedule

Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients

Utility of Commonly Used Commercial Human Chorionic Gonadotropin Immunoassays in the Diagnosis and Management of Trophoblastic Diseases

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

Phase I trial of elactocin

The views of health care professionals about selective decontamination of the digestive tract: An international, theoretically informed interview study

Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN)

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

Surveillance policy for stage I ovarian germ cell tumors

Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

Posterior reversible encephalopathy syndrome : a possible late interaction between cytotoxic agents and general anaesthesia

Suchergebnisse filtern